Skip to content

Compare two different methods of ultrasound-guided corticosteroid injection in the treatment of carpal tunnel syndrome

Comparing the two approaches, ulnar and radial injection with ultrasound guided in ???Carpal Tunnel ?Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180205038619N1
Enrollment
60
Registered
2018-03-05
Start date
2017-12-22
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal tunnel syndrome. Carpal tunnel syndrome

Interventions

Intervention 1: Intervention group: corticosteroid inject under the ultrasound-guid radial side of the median nerve which will be done by an experienced physical medicine and rehabilitation specialist

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Symptoms and signs of carpal tunnel syndrome (including pain and sensory disturbances in the Median nerve range) refer to the Physical Therapy and Rehabilitation Clinic and their disease is confirmed by EMG-NCS and Electrodiagnostic criteria have mild to moderate carpal tunnel syndrome They are entering the study

Exclusion criteria

Exclusion criteria: Severe Carpal Tunnel Syndrome with thenar atrophy Symptoms Contraindication of corticosteroid injection (including corticosteroid allergy and localized infections symptoms) Diseases that immitate CTS symptoms, such as polyneuropathy, cervical radiculopathy, thorasic outlet syndrome Surgical treatment or topical injection in the last six months. The origin of neoplastic or traumatic pain and fracture of the wrists.

Design outcomes

Primary

MeasureTime frame
The severity of symptoms and functional limitations. Timepoint: Zero, two, six and twelve weeks after. Method of measurement: By using Boston questionnare.;The severity of symptoms. Timepoint: Zero, two, six and twelve weeks after. Method of measurement: Visual Analog Scale(VAS).;Electrodiagnostic criteria. Timepoint: Zero, two, six and twelve weeks after. Method of measurement: By using EMG-NCV device.;Sonographic criteria. Timepoint: Zero, two, six and twelve weeks after. Method of measurement: By using Sonographic device.

Secondary

MeasureTime frame
Side effects. Timepoint: Two, six and twelve weeks after. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Arash Babaei

Iran University of Medical Sciences

babaei-ghazani.a@iums.ac.ir+98 21 8214 1229

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026